Results 191 to 200 of about 44,292,339 (363)
Qualitative and descriptive research: Data type versus data analysis
Hossein Nassaji
semanticscholar +1 more source
This study used longitudinal transcriptomics and gene‐pattern classification to uncover patient‐specific mechanisms of chemotherapy resistance in breast cancer. Findings reveal preexisting drug‐tolerant states in primary tumors and diverse gene rewiring patterns across patients, converging on a few dysregulated functional modules. Despite receiving the
Maya Dadiani+14 more
wiley +1 more source
Multiple Data Type Encryption Using Genetic Neural Network
The aim of this research is to build a ciphering system by using genetic neural network technique to protect data against unauthorized access to the data being transferred.The encryption data includes three stages: first Stage :- Using the genetic ...
Raid7 Al-Nima Ali N. Hamed+2 more
doaj
A Simplified Digital-Type Sampled-Data Controller
Fujio Nishida, Seiichi MIZUNO
openalex +2 more sources
U.S.G.S. marine geologic studies in the Beaufort Sea off northern Alaska, 1970 through 1972: Data type and location [PDF]
Peter W. Barnes+3 more
openalex +1 more source
HyComp: A hybrid cache compression method for selection of data-type-specific compression methods
A. Arelakis, F. Dahlgren, P. Stenström
semanticscholar +1 more source
B‐cell chronic lymphocytic leukemia (B‐CLL) and monoclonal B‐cell lymphocytosis (MBL) show altered proteomes and phosphoproteomes, analyzed using mass spectrometry, protein microarrays, and western blotting. Identifying 2970 proteins and 316 phosphoproteins, including 55 novel phosphopeptides, we reveal BCR and NF‐kβ/STAT3 signaling in disease ...
Paula Díez+17 more
wiley +1 more source
Ubiquitination of transcription factors in cancer: unveiling therapeutic potential
In cancer, dysregulated ubiquitination of transcription factors contributes to the uncontrolled growth and survival characteristics of tumors. Tumor suppressors are degraded by aberrant ubiquitination, or oncogenic transcription factors gain stability through ubiquitination, thereby promoting tumorigenesis.
Dongha Kim, Hye Jin Nam, Sung Hee Baek
wiley +1 more source
Targeted protein degradation in oncology: novel therapeutic opportunity for solid tumours?
Current anticancer therapies are limited by the occurrence of resistance and undruggability of most proteins. Targeted protein degraders are novel, promising agents that trigger the selective degradation of previously undruggable proteins through the recruitment of the ubiquitin–proteasome machinery. Their mechanism of action raises exciting challenges,
Noé Herbel, Sophie Postel‐Vinay
wiley +1 more source